BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24438683)

  • 21. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation.
    Manousou P; Burroughs AK; Tsochatzis E; Isgro G; Hall A; Green A; Calvaruso V; Ma GL; Gale J; Burgess G; O'Beirne J; Patch D; Thorburn D; Leandro G; Dhillon AP
    J Hepatol; 2013 May; 58(5):962-8. PubMed ID: 23262247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.
    Ladero JM; Delkader J; Ortega L; Fernández C; Devesa MJ; López-Alonso G; Mayol J; Cuenca F; Suárez A; Taxonera C; Díaz-Rubio M
    Scand J Gastroenterol; 2010; 45(1):51-9. PubMed ID: 20030577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.
    Cross TJ; Calvaruso V; Foxton MR; Manousou P; Quaglia A; Grillo F; Dhillon AP; Nolan J; Chang TP; O'Grady J; Heneghan MA; O'Beirne JP; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Sep; 17(9):640-9. PubMed ID: 19922441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
    Wai CT; Greenson JK; Fontana RJ; Kalbfleisch JD; Marrero JA; Conjeevaram HS; Lok AS
    Hepatology; 2003 Aug; 38(2):518-26. PubMed ID: 12883497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method.
    Maduli E; Andorno S; Rigamonti C; Capelli F; Morelli S; Colombi S; Nicosia G; Boldorini R; Abate M; Sartori M
    Ann Ital Med Int; 2002; 17(4):242-7. PubMed ID: 12532562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.
    Guéchot J; Boisson RC; Zarski JP; Sturm N; Calès P; Lasnier E;
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):467-72. PubMed ID: 23932706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of unidimensional transient elastography in staging chronic hepatitis C. Results from a cohort of 1,202 biopsied patients from one single center.
    Lupsor Platon M; Stefanescu H; Feier D; Maniu A; Badea R
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):157-66. PubMed ID: 23799214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
    Trépo E; Potthoff A; Pradat P; Bakshi R; Young B; Lagier R; Moreno C; Verset L; Cross R; Degré D; Lemmers A; Gustot T; Berthillon P; Rosenberg W; Trépo C; Sninsky J; Adler M; Wedemeyer H
    J Hepatol; 2011 Jul; 55(1):38-44. PubMed ID: 21145859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
    Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
    J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis.
    Goodman ZD; Becker RL; Pockros PJ; Afdhal NH
    Hepatology; 2007 Apr; 45(4):886-94. PubMed ID: 17393526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver biopsy assessment in chronic hepatitis.
    Lefkowitch JH
    Arch Med Res; 2007 Aug; 38(6):634-43. PubMed ID: 17613355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
    Sagrini E; Ardoino I; Marano G; Gianstefani A; Orlandini A; Sebastiani G; Donati G; Cucchetti A; Pelosi G; Ferrari C; Alberti A; Biganzoli E; Piscaglia F; Bolondi L
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1385-95. PubMed ID: 23839163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C.
    Nahon P; Thabut G; Ziol M; Htar MT; Cesaro F; Barget N; Grando-Lemaire V; Ganne-Carrie N; Trinchet JC; Beaugrand M
    Am J Gastroenterol; 2006 Dec; 101(12):2744-51. PubMed ID: 17227522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.